Tandem

Cover Block

Name	Tandem
Tagline	AI automating prior authorizations and medication access for prescriptions
Headquarters	New York, United States
Founded	2023
Stage	Growth / Late Stage
Business Model	B2B
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Funding Label	Undisclosed (total disclosed ~$100,000,000)

Links

• Website: https://withtandem.com/
• LinkedIn: https://www.linkedin.com/company/withtandem

What an Investor Needs First

Tandem is an AI-driven healthtech company automating the administrative burden of prescription access. The company's platform integrates into provider workflows to handle prior authorizations, insurance documentation, appeals, and pharmacy coordination [withtandem.com]. Its emergence addresses a high-friction component of U.S. healthcare delivery [Modern Healthcare, 2026].

The company was founded in 2023 and is led by Sahir Jaggi. The product is offered for free to providers and patients, with revenue generated through per-prescription fees, subscriptions, or value-based contracts [Entrepreneurloop, 2026].

Tandem's financial profile includes a reported $100 million funding round in 2026 that established a $1 billion valuation, with Accel noted as a lead investor [Crain's New York Business, 2026]; [MENA Fintech Association, 2026]. The company is backed by a syndicate including Pear VC, Lux Capital, Thrive Capital, and General Catalyst [Pear VC].

Over the next 12-18 months, key watchpoints include the translation of reported patient volume into named enterprise customer logos and validation of its business model at scale [Pear VC].

Data Accuracy: YELLOW -- Core product claims are sourced from the company site and investor page; the $1B valuation and $100M round are reported by multiple outlets but lack specific financial documentation.

Taxonomy Snapshot

Axis	Classification
Stage	Growth / Late Stage
Business Model	B2B
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Funding	Undisclosed (total disclosed ~$100,000,000)

Inside the Company

Tandem is a New York-based healthtech company founded in 2023 to automate prior authorizations and pharmacy coordination [withtandem.com]. The founding story and the identities of any co-founders beyond Sahir Jaggi are not detailed in public sources [Boring Business Nerd].

The company’s primary milestone is a reported $100 million funding round at a $1 billion valuation in 2026 [Modern Healthcare, 2026]; [Crain's New York Business, 2026]; [MENA Fintech Association, 2026]. Investor backing includes Pear VC, Accel, Lux Capital, and Thrive Capital [Pear VC]; [Crunchbase].

Data Accuracy: YELLOW -- Key milestone corroborated by multiple business publications; founding details and team composition lack public corroboration.

Under the Hood

Tandem’s product surfaces are defined by a single, high-friction workflow: the prior authorization. The company’s public materials describe an AI agent that integrates into a provider’s electronic health record or practice management system to automate the medication access process [withtandem.com]. The tool is free for both providers and patients [Modern Healthcare, 2026].

The platform checks insurance coverage, generates and submits clinical documentation, initiates appeals, seeks copay assistance, and routes prescriptions to pharmacies [Entrepreneurloop, 2026]. The company claims this happens without requiring physician intervention [withtandem.com].

• Revenue model. The business model involves charging healthcare practices through per-prescription fees, subscriptions, or value-based contracts [Entrepreneurloop, 2026].
• Technical stack. Inferences suggest a reliance on natural language processing for clinical notes, robotic process automation for form-filling, and integrations with pharmacy benefit manager and EHR APIs.
• Scale claim. The platform supports "thousands of patients weekly" [Pear VC].

Data Accuracy: YELLOW -- Product claims are consistent across the company website and secondary press reports, but technical specifics and detailed deployment evidence are not publicly available.

Market Research

Prior authorization has become a primary friction point in U.S. healthcare. A 2022 American Medical Association survey found that medical practices complete an average of 45 prior authorizations per physician per week, with 88% of physicians describing the burden as high or extremely high. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), effective 2026, requires certain payers to implement electronic prior authorization APIs, creating a compliance-driven market tailwind [Modern Healthcare, 2026].

Metric	Value
U.S. Prior Auth Burden (Analogous)	45 authorizations/physician/week
Estimated Industry Cost (Analogous)	30 $B annually
CMS Rule Effective Date	2026 year

Data Accuracy: YELLOW -- Market sizing relies on analogous industry survey data; regulatory catalyst is confirmed by trade press.

Competition and Substitutes

Tandem enters a crowded field, positioning itself as a free-to-provider, end-to-end workflow automation layer.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Tandem	AI automating prior authorizations, pharmacy coordination, and medication affordability end-to-end.	Growth stage; ~$100M funding at $1B valuation (estimated) [Modern Healthcare, 2026].	Zero-cost model for providers, integrated workflow for appeals and copay assistance.	[withtandem.com]
Cohere Health	AI-powered prior authorization platform focused on specialty care and value-based payment models.	Late stage; $106M Series C in 2023 [Fierce Healthcare, 2023].	Deep integration with health plans and focus on clinical appropriateness.	[Fierce Healthcare, 2023]

Data Accuracy: YELLOW -- Competitor Cohere Health's funding and positioning are confirmed by trade press. Tandem's differentiation claims are sourced from its website and a startup blog.

Opportunity

The prize for automating the $31 billion administrative burden of prior authorizations is a fundamental re-architecting of prescription access. Tandem targets prior authorizations by offering its service for free to providers and patients, aiming to achieve critical adoption volume before layering in monetization [Pear VC].

Scenario	What happens	Catalyst	Why it's plausible
Payor Partnership	Health insurers and PBMs license Tandem's AI to automate their own prior auth review.	A public announcement of a pilot or contract with a regional or national payer.	Payers spend billions manually reviewing prior auth requests [Entrepreneurloop, 2026].
Pharma Integration	Pharmaceutical companies embed Tandem's access platform into their patient support programs.	A partnership with a top-20 pharma company's market access team.	Optimizing medication affordability and pharmacy routing is a core stated function [withtandem.com].

Data Accuracy: YELLOW -- Growth scenarios are extrapolated from stated product capabilities and broad market logic; the $1B valuation claim is reported by multiple outlets but lacks detailed round confirmation.

Sources

1. [withtandem.com] Tandem | AI for Prior Authorizations & Medication Access Support | https://withtandem.com/
2. [Modern Healthcare, 2026] AI-for-prescriptions startup Tandem lands $1B valuation | https://www.modernhealthcare.com/health-tech/ai/mh-ai-prescriptions-tandem-valuation/
3. [Entrepreneurloop, 2026] Tandem AI prescription startup billion valuation 2026 | https://entrepreneurloop.com/tandem-ai-prescription-startup-billion-valuation-2026/
4. [Crain's New York Business, 2026] Tandem Technology lands $1B valuation | https://www.crainsnewyork.com/health-pulse/tandem-technology-lands-1b-valuation/
5. [MENA Fintech Association, 2026] Tandem Technology to Raise $100 Million for Prescription Automation | https://mena-fintech.org/news/tandem-technology-to-raise-100-million-for-prescription-automation/
6. [Pear VC] Tandem | https://pear.vc/companies/tandem/
7. [Boring Business Nerd] Sahir Jaggi | https://www.boringbusinessnerd.com/investor/sahir-jaggi
8. [Crunchbase] Tandem - Products, Competitors, Financials, Employees, Headquarters Locations | https://www.cbinsights.com/company/tandem-8
9. [Healthcare Huddle] Prior Authorization AI: The Arms Race That Won't Fix Healthcare | https://www.healthcarehuddle.com/p/prior-authorization-ai-the-arms-race-that-won-t-fix-healthcare
10. [Fierce Healthcare, 2023] Cohere Health raises $106M for AI-powered prior authorization | https://www.fiercehealthcare.com/health-tech/cohere-health-raises-106m-series-c-ai-powered-prior-authorization
11. [LinkedIn] Tandem | https://www.linkedin.com/company/withtandem